Industry Perspectives
| 3 min read
Illumina and pharma partners will develop companion diagnostics for historically important KRAS biomarker
| 3 min read
The new diagnostic enables rapid identification of acute leukaemia patients with KMT2A rearrangements for precision therapy.
| 8 min read
Jo Varshney explains how human-relevant models and mechanistic simulations are transforming early-stage drug discovery and development.
| 2 min read
QIAGEN Digital Insights bioinformatics bring over 25 years of expertise in expert-curated content, AI-powered proprietary algorithms and user-friendly tools to simplify NGS data analysis
| 3 min read
The growing Alliance continues to build the most comprehensive clinical genomic dataset to advance human health.
| 6 min read
Researchers can now train AI models on over 5 million protein-ligand structures to predict drug potency faster and more accurately than ever.
| 2 min read
Specialized AI agents automate research workflows and accelerate drug discovery and development with transparent, evidence-backed insights.
| 3 min read
New study finds limited value from nearly one-third of clinical trial procedures and associated data, highlighting opportunity for more patient-centric trial design
| 2 min read
New integration brings real-time, in-line monitoring of glucose and lactate to bioprocess development.
| 2 min read
First commercially available cell culture solution for HEK293 cells and perfusion, optimized for high cell density, intensified processes and perfusion cultures.
| 6 min read
Avidity remains on track to submit Biologics License Application at the end of 2025 for accelerated approval
| 6 min read
AI is changing how experiments are designed, executed, and interpreted in early-stage drug discovery.
